@article{20e7f3f34dd64c668787d9e7f63b11f4,
title = "Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy",
abstract = "N/A",
keywords = "Clopidogrel, Humans, Percutaneous Coronary Intervention, Prasugrel Hydrochloride, Purinergic P2Y Receptor Antagonists, Ticagrelor, Clopidogrel, Humans, Percutaneous Coronary Intervention, Prasugrel Hydrochloride, Purinergic P2Y Receptor Antagonists, Ticagrelor",
author = "Filippo Crea",
year = "2021",
doi = "10.1093/eurheartj/ehab277",
language = "English",
volume = "42",
pages = "2973--2985",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
}